Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-04-22 @ 3:45 PM
Study NCT ID:
NCT06108050
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2023-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Sponsor:
Jazz Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JZP898-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |